Investors & Media


Altamira Therapeutics is dedicated to developing therapeutics that address important unmet medical needs. The Company is currently active in RNA therapeutics, allergy and viral infections, and inner ear disorders. The Company was founded in 2003 and is headquartered in Hamilton, Bermuda with its main operations in Basel, Switzerland. The shares of Altamira Therapeutics Ltd. trade on the NASDAQ Capital Market under the symbol “CYTO.”

Latest Events

Altamira Therapeutics to Host Conference Call and Webcast to Provide Business Update on Bentrio™ Program
Monday, September 27, 2021, at 2:00 pm CEST
To participate telephonically, please dial (888) 506-0062 (U.S.) or (973) 528-0011 (international), conference code 590321.
View Webcast

Investor Contact

Primary IR Contacts

Stephen Kilmer
E-Mail: or

Stock Quote


Recent Press Releases